Zobrazeno 1 - 10
of 571
pro vyhledávání: '"Celestia S, Higano"'
Autor:
Celestia S. Higano, Daniel J. George, Neal D. Shore, Oliver Sartor, Kurt Miller, Peter S. Conti, Cora N. Sternberg, Fred Saad, Juan Pablo Sade, Joaquim Bellmunt, Matthew R. Smith, Kumari Chandrawansa, Per Sandström, Frank Verholen, Bertrand Tombal
Publikováno v:
EClinicalMedicine, Vol 60, Iss , Pp 101993- (2023)
Summary: Background: Radium-223, a targeted alpha therapy, is approved to treat bone-dominant metastatic castration-resistant prostate cancer (mCRPC), based on significantly prolonged overall survival versus placebo and a favourable safety profile in
Externí odkaz:
https://doaj.org/article/ede8b4395fd74aa190c82bdfe489b529
Autor:
Tian Zhang, Nicholas J Vogelzang, Daniel P Petrylak, Ravi A Madan, Karen A Autio, Ray Li, Helen Cho, Szu-Yu Tang, Celestia S Higano, Luke Nordquist, Leonard J Appleman, Xin-Hua Zhu, Hani Babiker, Sandip M Prasad, Michael T Schweizer, Stephane Billotte, Nora Cavazos, Orlaith Bogg, Kam Chan, Megan Kaneda, I-Ming Wang, Jenny Zheng, Robert Hollingsworth, Kenneth A Kern
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
Background This phase 1 study evaluated PF-06753512, a vaccine-based immunotherapy regimen (PrCa VBIR), in two clinical states of prostate cancer (PC), metastatic castration-resistant PC (mCRPC) and biochemical recurrence (BCR).Methods For dose escal
Externí odkaz:
https://doaj.org/article/a4a8a3a078ab4567a1641ae4c2b5d1db
Autor:
Sylvie D. Lambert, Lindsay R. Duncan, S. Nicole Culos-Reed, Laura Hallward, Celestia S. Higano, Ekaterina Loban, Anne Katz, Manon De Raad, Janet Ellis, Melissa B. Korman, Carly Sears, Cindy Ibberson, Lauren Walker, Eric Belzile, Paramita Saha-Chaudhuri, Helen McTaggart-Cowan, Stuart Peacock
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 785-804 (2022)
Background: Prostate cancer is the most common cancer diagnosis among men. Family caregivers (often female spouses) play a key role in ensuring patients’ needs are met, frequently assuming their role with no formal training, which can contribute to
Externí odkaz:
https://doaj.org/article/45c92b4440974b3286db8e9ded878b33
Autor:
Dionna Jacobson, Benoit Cadieux, Celestia S. Higano, David H. Henry, Basia A. Bachmann, Marko Rehn, Alison T. Stopeck, Hossam Saad
Publikováno v:
Journal of Bone Oncology, Vol 34, Iss , Pp 100423- (2022)
Background: Clinical practice guidelines recommend the use of bone-targeting agents for preventing skeletal-related events (SREs) among patients with bone metastases from solid tumors. The anti-RANKL monoclonal antibody denosumab is approved for the
Externí odkaz:
https://doaj.org/article/d9d83d9457b64c0bb7e80b98fa064670
Autor:
Rahul Aggarwal, Joshi J. Alumkal, Russell Z. Szmulewitz, Celestia S. Higano, Alan H. Bryce, Angela Lopez-Gitlitz, Sharon A. McCarthy, Branko Miladinovic, Kelly McQuarrie, Shibu Thomas, Ke Zhang, Eric J. Small
Publikováno v:
Prostate Cancer, Vol 2022 (2022)
Purpose. This randomized phase 2 study sought to assess the treatment effect of a finite duration of apalutamide with and without androgen deprivation therapy (ADT) in biochemically recurrent prostate cancer (BCR PC). Materials and Methods. Patients
Externí odkaz:
https://doaj.org/article/ca0c2ba8c68e4aca981effd45231b1a2
Autor:
Yu Jiang, Travis J. Meyers, Adaeze A. Emeka, Lauren Folgosa Cooley, Phillip R. Cooper, Nicola Lancki, Irene Helenowski, Linda Kachuri, Daniel W. Lin, Janet L. Stanford, Lisa F. Newcomb, Suzanne Kolb, Antonio Finelli, Neil E. Fleshner, Maria Komisarenko, James A. Eastham, Behfar Ehdaie, Nicole Benfante, Christopher J. Logothetis, Justin R. Gregg, Cherie A. Perez, Sergio Garza, Jeri Kim, Leonard S. Marks, Merdie Delfin, Danielle Barsa, Danny Vesprini, Laurence H. Klotz, Andrew Loblaw, Alexandre Mamedov, S. Larry Goldenberg, Celestia S. Higano, Maria Spillane, Eugenia Wu, H. Ballentine Carter, Christian P. Pavlovich, Mufaddal Mamawala, Tricia Landis, Peter R. Carroll, June M. Chan, Matthew R. Cooperberg, Janet E. Cowan, Todd M. Morgan, Javed Siddiqui, Rabia Martin, Eric A. Klein, Karen Brittain, Paige Gotwald, Daniel A. Barocas, Jeremiah R. Dallmer, Jennifer B. Gordetsky, Pam Steele, Shilajit D. Kundu, Jazmine Stockdale, Monique J. Roobol, Lionne D.F. Venderbos, Martin G. Sanda, Rebecca Arnold, Dattatraya Patil, Christopher P. Evans, Marc A. Dall’Era, Anjali Vij, Anthony J. Costello, Ken Chow, Niall M. Corcoran, Soroush Rais-Bahrami, Courtney Phares, Douglas S. Scherr, Thomas Flynn, R. Jeffrey Karnes, Michael Koch, Courtney Rose Dhondt, Joel B. Nelson, Dawn McBride, Michael S. Cookson, Kelly L. Stratton, Stephen Farriester, Erin Hemken, Walter M. Stadler, Tuula Pera, Deimante Banionyte, Fernando J. Bianco, Jr., Isabel H. Lopez, Stacy Loeb, Samir S. Taneja, Nataliya Byrne, Christopher L. Amling, Ann Martinez, Luc Boileau, Franklin D. Gaylis, Jacqueline Petkewicz, Nicholas Kirwen, Brian T. Helfand, Jianfeng Xu, Denise M. Scholtens, William J. Catalona, John S. Witte
Publikováno v:
HGG Advances, Vol 3, Iss 1, Pp 100070- (2022)
Summary: Men diagnosed with low-risk prostate cancer (PC) are increasingly electing active surveillance (AS) as their initial management strategy. While this may reduce the side effects of treatment for PC, many men on AS eventually convert to active
Externí odkaz:
https://doaj.org/article/dd671a3166f5492e9f3db2429cd59265
Autor:
Chiara Melloni, MD, MHS, Susan F. Slovin, MD, PhD, Allan Blemings, MS, Shaun G. Goodman, MD, MSc, Christopher P. Evans, MD, Jan Nilsson, MD, Deepak L. Bhatt, MD, MPH, Konstantin Zubovskiy, MD, Tine K. Olesen, MS, MBA, Klaus Dugi, MD, Noel W. Clarke, MBBS, ChM, Celestia S. Higano, MD, Matthew T. Roe, MD, MHS
Publikováno v:
JACC. CardioOncology, Vol 2, Iss 1, Pp 70-81 (2020)
Objectives: This study will compare the incidence of major adverse cardiovascular events (MACEs) with androgen deprivation therapy (ADT) among men with advanced prostate cancer who are being treated with a gonadotropin-releasing hormone (GnRH) antago
Externí odkaz:
https://doaj.org/article/dfc10cb0c1f24371b8b3b6de0c4a2d51
Autor:
Susan Halabi, Qian Yang, Akash Roy, Bin Luo, John C. Araujo, Christopher Logothetis, Cora N. Sternberg, Andrew J. Armstrong, Michael A. Carducci, Kim N. Chi, Johann S. de Bono, Daniel P. Petrylak, Karim Fizazi, Celestia S. Higano, Michael J. Morris, Dana E. Rathkopf, Fred Saad, Charles J. Ryan, Eric J. Small, William Kevin Kelly
Publikováno v:
Journal of Clinical Oncology. 41:2736-2746
PURPOSE We have previously developed and externally validated a prognostic model of overall survival (OS) in men with metastatic, castration-resistant prostate cancer (mCRPC) treated with docetaxel. We sought to externally validate this model in a br
Publikováno v:
Sexual Medicine, Vol 9, Iss 2, Pp 100310- (2021)
Introduction: Sexual health and intimacy are consistently reported among the top unmet supportive care needs of prostate cancer (PC) survivors. With an aging population and advances in PC detection and treatment, the need for better PC sexual health
Externí odkaz:
https://doaj.org/article/f1b97e91ed75440da70caa069f111955
Autor:
Bibiana M Kemerer, Bozena Zdaniuk, Celestia S Higano, Jennifer A Bossio, Raysa Camara Bicalho Santos, Ryan Flannigan, Lori A Brotto
Publikováno v:
The Journal of Sexual Medicine. 20:346-366
BackgroundSexual dysfunction is the most common and most distressing consequence of prostate cancer (PCa) treatment and has been shown to directly affect the sexual function and quality of life of survivors’ partners. There are currently no establi